SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-21-033108
Filing Date
2021-06-16
Accepted
2021-06-16 08:55:45
Documents
14
Period of Report
2021-06-15
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K acor-8k_20210615.htm   iXBRL 8-K 34507
2 EX-99.1 acor-ex991_15.htm EX-99.1 11589
3 GRAPHIC grlzv2mbwvir000001.jpg GRAPHIC 4764
  Complete submission text file 0001564590-21-033108.txt   182489

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA acor-20210615.xsd EX-101.SCH 5768
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE acor-20210615_lab.xml EX-101.LAB 18732
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE acor-20210615_pre.xml EX-101.PRE 11167
7 EXTRACTED XBRL INSTANCE DOCUMENT acor-8k_20210615_htm.xml XML 3419
Mailing Address 420 SAW MILL RIVER ROAD ARDSLEY NY 10502
Business Address 420 SAW MILL RIVER ROAD ARDSLEY NY 10502 914-347-4300
ACORDA THERAPEUTICS INC (Filer) CIK: 0001008848 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-31938 | Film No.: 211020557
SIC: 2836 Biological Products, (No Diagnostic Substances)